CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionProfit margin is 38.2%, higher than 95% of its Medical Instruments & Supplies peers (median 8.2%)
- FinancialsAltman Z-Score 3.69: safe zone
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
5.68%
Annual Rate
JPY 28.00Paid semi-annual
Payout Ratio
75.7%Moderate
Next Ex-Dividend
Dec 29, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
54.81BJPY343.38M · vs all stocks (USD)
Trailing P/E
14.39xvs Medical Instruments & Supplies peers
Revenue (TTM)
14.37BJPY90.03M · vs all stocks (USD)
Profit Margin
38.24%vs Medical Instruments & Supplies peers
Beta
0.7260xvs all stocks
52-Week Change
-17.67%vs all stocks
Forward Annual Dividend Yield
5.68%vs all stocks
Market Capitalization
54.81BJPY343.38M · vs all stocks (USD)
Enterprise Value
69.65BJPY436.42M · vs all stocks (USD)
Trailing P/E
14.39xvs Medical Instruments & Supplies peers
Forward P/E
7.88xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
3.66xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.71xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.85xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
13.08xvs Medical Instruments & Supplies peers
Profit Margin
38.24%vs Medical Instruments & Supplies peers
Operating Margin
18.63%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
6.47%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
29.83%vs Medical Instruments & Supplies peers
Revenue (TTM)
14.37BJPY90.03M · vs all stocks (USD)
Revenue per Share (TTM)
136.71JPYUpdated Aug 19, 2026Quarterly Revenue Growth
263.30%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
8.82BJPY55.27M · vs all stocks (USD)
EBITDA (TTM)
9.04BJPY56.63M · vs all stocks (USD)
Net Income (TTM)
5.50BJPY34.43M · vs all stocks (USD)
Operating Cash Flow (TTM)
-2.83BJPY-17.70M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-11.82BJPY-74.03M · vs all stocks (USD)
Forward Annual Dividend Rate
28.00JPYUpdated Aug 19, 2026Forward Annual Dividend Yield
5.68%vs all stocks
Trailing Annual Dividend Rate
28.00JPYUpdated Aug 19, 2026Trailing Annual Dividend Yield
5.68%vs all stocks
Payout Ratio
75.74%vs Medical Instruments & Supplies peers
Revenue
18.63BJPYFY2025 · Jun 30, 2025Cost of Goods Sold
5.85BJPYFY2025 · Jun 30, 2025Gross Profit
12.77BJPYFY2025 · Jun 30, 2025Operating Income
8.27BJPY51.78M · vs all stocks (USD)
Pre-tax Income
8.20BJPYFY2025 · Jun 30, 2025Income Tax Expense
1.89BJPYFY2025 · Jun 30, 2025Net Income
6.32BJPYFY2025 · Jun 30, 2025EBIT
8.30BJPYFY2025 · Jun 30, 2025EBITDA (Income Statement)
9.04BJPYFY2025 · Jun 30, 2025Selling, General & Administrative
2.63BJPYFY2025 · Jun 30, 2025Non-operating Interest Income
7.04MJPYFY2025 · Jun 30, 2025Non-operating Interest Expense
102.90MJPYFY2025 · Jun 30, 2025EPS (Basic)
62.07JPYFY2025 · Jun 30, 2025EPS (Diluted)
58.90JPYFY2025 · Jun 30, 2025Basic Shares Outstanding
101.74MSharesFY2025 · Jun 30, 2025Diluted Shares Outstanding
101.74MSharesFY2025 · Jun 30, 2025Preferred Stock Dividends
0.00JPYFY2025 · Jun 30, 2025Operating Cash Flow
9.92BJPYFY2025 · Jun 30, 2025Free Cash Flow
5.24BJPYFY2025 · Jun 30, 2025Cash & Cash Equivalents (End of Period)
9.27BJPYFY2025 · Jun 30, 2025Starting Profit (CF Statement)
8.20BJPYFY2025 · Jun 30, 2025Other Non-cash Items
219.94MJPYFY2025 · Jun 30, 2025Change in Accounts Receivable (CF)
2.46BJPYFY2025 · Jun 30, 2025Change in Other Assets/Liabilities
-965.62MJPYFY2025 · Jun 30, 2025Capital Expenditures
-4.68BJPYFY2025 · Jun 30, 2025Net Intangibles (CF)
-440.35MJPYFY2025 · Jun 30, 2025Net Acquisitions
0.00JPYFY2025 · Jun 30, 2025Purchase of Investments
-4.14BJPYFY2025 · Jun 30, 2025Net Investing Cash Flow
-8.82BJPYFY2025 · Jun 30, 2025Long-term Debt Issuance
5.64BJPYFY2025 · Jun 30, 2025Long-term Debt Payments
-757.00MJPYFY2025 · Jun 30, 2025Net Short-term Debt Issuance
0.00JPYFY2025 · Jun 30, 2025Common Dividends Paid
-2.78BJPYFY2025 · Jun 30, 2025Other Financing Charges
-1.00KJPYFY2025 · Jun 30, 2025Net Financing Cash Flow
2.28BJPYFY2025 · Jun 30, 2025Shares Outstanding
106.40MSharesUpdated Aug 19, 2026Float Shares
29.54MSharesUpdated Aug 19, 2026% Held by Insiders
68.76%vs all stocks
% Held by Institutions
3.52%vs all stocks
Total Cash (MRQ)
3.56BJPY22.33M · vs all stocks (USD)
Total Cash per Share (MRQ)
33.40JPYUpdated Aug 19, 2026Total Debt (MRQ)
21.26BJPY133.20M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.09xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.26xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
182.03JPYUpdated Aug 19, 2026Total Assets
36.52BJPY228.79M · vs all stocks (USD)
Total Current Assets
15.48BJPYFY2025 · Jun 30, 2025Total Liabilities
19.10BJPYFY2025 · Jun 30, 2025Total Non-current Assets
21.04BJPYFY2025 · Jun 30, 2025Total Non-current Liabilities
9.57BJPYFY2025 · Jun 30, 2025Total Current Liabilities
9.53BJPYFY2025 · Jun 30, 2025Cash & Cash Equivalents
9.27BJPYFY2025 · Jun 30, 2025Accounts Receivable
247.78MJPYFY2025 · Jun 30, 2025Inventory
5.88BJPYFY2025 · Jun 30, 2025Accounts Payable
1.20BJPYFY2025 · Jun 30, 2025Short-term Debt
5.61BJPYFY2025 · Jun 30, 2025Other Current Liabilities
197.79MJPYFY2025 · Jun 30, 2025Long-term Debt
8.81BJPYFY2025 · Jun 30, 2025Other Non-current Liabilities
5.00KJPYFY2025 · Jun 30, 2025Common Stock (Book)
289.77MJPYFY2025 · Jun 30, 2025Retained Earnings
13.31BJPYFY2025 · Jun 30, 2025Total Shareholders' Equity
17.42BJPY109.13M · vs all stocks (USD)
52-Week Low
463.00JPYUpdated Aug 19, 202652-Week High
603.00JPYUpdated Aug 19, 202652-Week Change
-17.67%vs all stocks
Beta
0.7260xvs all stocks
50-Day MA
477.52JPYUpdated Aug 19, 2026200-Day MA
508.48JPYUpdated Aug 19, 2026Avg 10-Day Volume
357.46KSharesUpdated Aug 19, 2026Avg 30-Day Volume
329.27KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
34.33JPYUpdated Aug 19, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is 38.2%, higher than 95% of its Medical Instruments & Supplies peers (median 8.2%)Significant
Profit margin: 0.38Industry median: 0.08Industry P95: 0.25Peers compared: 65.00
Return on equity is 29.8%, higher than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: 0.30Industry median: 0.06Industry P95: 0.21Peers compared: 65.00
P/E ratio is 14.39×, lower than 95% of its Medical Instruments & Supplies peers (median 30.34×)Notable
P/E ratio: 14.39Industry median: 30.34Industry P5: 14.42Peers compared: 65.00
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 34,430,170.788Operating Cash Flow (USD, TTM): -17,702,393.328
Financial Health
Altman Z-Score 3.69: safe zoneNotable
Altman Z-Score: 3.69
High earnings qualityNotable
Earnings Quality Score: 0.99
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Xinlong Holding Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Qingdao Daneng Environment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Guangdong Faith Long Crystal Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangxi Everbright Measurement & Control Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Mayur Uniquoters Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Qingdao Richmat Intelligence Technology Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Guangzhou Seagull Kitchen & Bath Products Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Saint Bella Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Strattec Security Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangzhou Jet Biofiltration Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Alliance Material Co., Ltd.
5 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net Levels
Travel Food Services Limited
5 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net Levels
Aryt Industries Ltd.
5 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net Levels